Psp140: an immunodominant antigen in the supernatant of Streptococcus pneumoniae culture
- PMID: 32994906
- PMCID: PMC7502138
- DOI: 10.18502/ijm.v12i4.3938
Psp140: an immunodominant antigen in the supernatant of Streptococcus pneumoniae culture
Abstract
Background and objectives: Streptococcus pneumoniae causes many lethal infections. Due to its reduced sensitivity to commonly used antibiotics, development of new strategies against pneumococcal infections seems to be necessary. We aimed to investigate immunodominant antigens in S. pneumoniae culture supernatant in order to develop novel targets for pneumococcal vaccines.
Materials and methods: In this study S. pneumoniae ATCC49619 was sub-cultured into BHI broth from overnight culture at 37°C for 4 h. The supernatant proteins were precipitated using acetone precipitation method. A rabbit was intramuscularly immunized with alum adjuvant and 100 μg pneumococcal supernatant proteins, 6 times at 14 days' intervals to produce hyperimmune serum. ELISA assay was performed to determine the antibody level response to pneumococcal secretory proteins. Then dot blot applied for rapid evaluation of hyperimmune serum reactivity to pneumococcus supernatant proteins. The western blot was also used to determine the interaction of supernatant proteins with immunogenic rabbit's hyperimmune-serum.
Results: According to the western blot analysis, the immunodominant protein had 140KDa molecular weight and designated as pneumococcal secretory protein140 (Psp140).
Conclusion: The Psp140 protein in the supernatant of S. pneumoniae culture is an immunodominant protein and it is likely related to pneumococcal secretory protein or surface exposed protein which released into culture supernatant during bacterial growth.
Keywords: Enzyme-linked immunosorbent assay; Immunodominant antigen; Streptococcus pneumoniae; Western blot.
Copyright© 2020 Iranian Society of Microbiology & Tehran University of Medical Sciences.
Figures



Similar articles
-
Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.Vaccine. 2007 Jun 28;25(27):4996-5005. doi: 10.1016/j.vaccine.2007.04.069. Epub 2007 May 11. Vaccine. 2007. PMID: 17524530
-
Evaluation of Protective Efficacy of Selected Immunodominant B-Cell Epitopes within Virulent Surface Proteins of Streptococcus pneumoniae.Infect Immun. 2018 Feb 20;86(3):e00673-17. doi: 10.1128/IAI.00673-17. Print 2018 Mar. Infect Immun. 2018. PMID: 29263108 Free PMC article.
-
CbpM and CbpG of Streptococcus Pneumoniae Elicit a High Protection in Mice Challenged with a Serotype 19F Pneumococcus.Iran J Allergy Asthma Immunol. 2018 Dec 3;17(6):574-585. Iran J Allergy Asthma Immunol. 2018. PMID: 30644702
-
Otitis media: the chinchilla model.Microb Drug Resist. 1999 Spring;5(1):57-72. doi: 10.1089/mdr.1999.5.57. Microb Drug Resist. 1999. PMID: 10332723 Review.
-
Pneumococcal virulence factors: structure and function.Microbiol Mol Biol Rev. 2001 Jun;65(2):187-207 ; first page, table of contents. doi: 10.1128/MMBR.65.2.187-207.2001. Microbiol Mol Biol Rev. 2001. PMID: 11381099 Free PMC article. Review.
References
-
- Farajzadeh Sheikh A, Ahmadi K, Nikakhlagh S. Detection of Streptococcus pneumoniae and Moraxella catarrhalis in patients with paranasal chronic sinusitis by polymerase chain reaction method. J Chin Med Assoc 2016;79:440–444. - PubMed
-
- Lu CY, Ting YT, Huang LM. Severe Streptococcus pneumoniae 19A pneumonia with empyema in children vaccinated with pneumococcal conjugate vaccines. J Formos Med Assoc 2015;114:783–784. - PubMed
-
- Castillo EM, Rickman LS, Brodine SK, Ledbetter EK, Kelly C. Streptococcus pneumoniae: bacteremia in an era of penicillin resistance. Am J Infect Control 2000;28:239–243. - PubMed
-
- Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010;375:1969–1987. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases